Wordt geladen...
New Strategies in Bladder Cancer: A Second Coming for Immunotherapy
Urothelial bladder cancer (UBC) remains one of the most common and deadly cancers worldwide, and platinum based chemotherapy, which has been the standard of care in metastatic bladder cancer, has had limited success in improving outcomes for patients. The recent development and translation of therap...
Bewaard in:
| Gepubliceerd in: | Clin Cancer Res |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825862/ https://ncbi.nlm.nih.gov/pubmed/26683632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-1135 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|